Key result
Sequential venous and arterial thromboembolisms reveal occult advanced prostate cancer in an older male.
Why the study?
Patients presenting with unexplained arterial and venous thromboembolic events without traditional risk factors require thorough evaluation for underlying causes such as malignancies.
Case Report (n=1)
No
This case emphasizes the necessity of investigating underlying malignancies in patients presenting with unexplained concurrent arterial and venous thromboembolic events, especially those showing signs of disseminated intravascular coagulation.
Answers are grounded in this paper and cite their sources.
Supports targeted malignancy evaluation in unexplained thromboembolic events; leaves open whether systematic screening improves outcomes in larger cohorts.
Introduction: Current versatile treatments for acute vessel occlusion - whether arterial or venous - have significantly improved the success of recanalization. However, patients who present with unexplained thromboembolic events, including arterial and venous, especially in the absence of traditional risk factors, should undergo thorough evaluation for potential underlying causes, including malignancies. Case Presentation: A 66-year-old man experienced deep vein thrombosis of the left femoral vein and underwent catheter-directed thrombolysis followed by rivaroxaban therapy. Two weeks later, he presented with acute drowsiness, right-sided hemiparesis, and left hemineglect. Brain magnetic resonance imaging revealed acute multiple infarcts. During hospitalization, laboratory findings indicated disseminated intravascular coagulation. Further evaluation showed a markedly elevated prostate-specific antigen level, prompting prostate magnetic resonance imaging, which revealed advanced prostate cancer with staging of cT4N1M1a. The diagnosis was confirmed by biopsy. Hormone therapy with degarelix was initiated. Atrial fibrillation also developed during the hospital stay, and apixaban was prescribed. The patient demonstrated continuous clinical improvement and achieved a modified Rankin Scale score of 2 at 9 months post-stroke. Conclusion: This case highlights the importance of thorough investigation in patients with unusual thromboembolic events, both arterial and venous. Timely diagnosis and treatment of underlying malignancy are crucial in preventing recurrence of cancer-related stroke.
No takes yet. Share an insight, caveat, or question.
Chen et al. (2025) conducted a case report in Thromboembolic events (DVT and ischemic stroke) associated with advanced prostate cancer (n=1). Diagnostic evaluation and multidisciplinary treatment (degarelix, apixaban) was evaluated. A 66-year-old man presenting with unusual sequential venous and arterial thromboembolic events was diagnosed with advanced prostate cancer, demonstrating the importance of malignancy screening in unexplained thromboses.
Synapse has enriched 10 related papers. Consider them for comparative context: